Voyager Therapeutics
VYGR | NASDAQ
$1.63
-$0.10 (-5.78%)
At close: Nov 16, 2026, 4:00 PM ET
$1.62
-$0.01 (-0.61%)
After-hours:
Nov 16, 2026, 7:39 PM ET
Voyager Therapeutics Statistics
Key statistics explainedMarket Data
$101.43M
$25.13M
1.20
692.72K
61.82M
5.14%
58.15%
NASDAQ
US92915B1061
Price Performance
-14.2%
-49.5%
-53.8%
-58.5%
-60.3%
-76.1%
-52.3%
-14.2%
-58.5%
-12.1%
-18.9%
Valuation
-0.94
N/A
-0.04
0.04
4.04
2.60
0.75
-0.92
-0.84
-0.92
1.00
-0.31
-0.33
-0.23
-106.8%
-108.3%
-119.2%
Financial Health
$76.3M
$30.51M
$106.81M
$177.05M
6.81
6.81
0.23
-0.40
-0.28
-3.58
0.00
-3.28
2
Margins & Profitability
100.0%
-344.9%
-404.6%
-416.3%
-437.4%
-481.4%
44.0%
-10.1%
Returns
-59.0%
-63.4%
-67.8%
-70.5%
-59.0%
Historical Growth (CAGR)
-45.9%
9.6%
4.1%
-115.2%
-123.9%
14.8%
-47.3%
-136.3%
-12.3%
Analyst Forecasts
Buy
1
8.4%
39.0%
Mar 8, 2027
-$0.34
-26.1%
$9.02M
-41.2%
Fair Value Estimates
N/A
N/A
N/A
N/A
$18.00
1004.3%
Cash Flow
$-109.19M
$-109.83M
$-120.88M
-$1.78
-$1.77
-434.9%
Income Statement
$25.11M
$21.09M
$-86.59M
$-76.9M
$-104.53M
-$1.74
$178.07K
$-741.35K
141
Add to Watchlist
Select watchlists to add or remove VYGR